$0.5100
0.01442.91%
Last update: Oct 23, 8:29 AM
Jasper Therapeutics Inc (JSPR) Stock Price, Quote, News & History
JSPRNASDAQ
Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are happening.
You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.
Other companies in Jasper Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Jasper Therapeutics has a consensus price target of $8.39.
The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $0.494732 last updated October 23, 2026 at 8:29 AM EDT.
There are no upcoming dividends for Jasper Therapeutics.
Jasper Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Jasper Therapeutics.
Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead...
